NTRK1 (P04629) variants and mutations
NTRK1 (also known as P04629) is a human protein-coding gene encoding a high affinity nerve growth factor receptor protein. Nerve-growth-factor signaling through this pathway supports survival and differentiation of sensory and sympathetic neurons. Loss-of-function variants cause congenital insensitivity to pain with anhidrosis, whereas oncogenic NTRK1 fusions can drive diverse cancers. This analysis covers 3,221 NTRK1 variants and mutations. Of these, 44% have computational variant effect predictions. Disease context includes hereditary sensory and autonomic neuropathy type 4, non-small cell lung carcinoma, and neoplasm. Example NTRK1 variants include M1?, M1I, and M1K.
Variant analysis overview
- Gene: NTRK1
- Protein: P04629
- UniProt accession: P04629
- Organism: Homo sapiens
- Variants analyzed: 3221
- Variant scope: all variants
- Completed: 2026-08-10
Variant and mutation evidence
- Variant composition: 2,968 unspecified-consequence records; 163 missense variants; 67 synonymous variants; 12 frameshift variants; 8 stop-gained variants; 2 in-frame deletions; 1 splice-region variants
- Prediction scores: 1,421 variants have prediction scores (44% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hereditary sensory and autonomic neuropathy type 4, non-small cell lung carcinoma, neoplasm, cancer, colorectal cancer, familial medullary thyroid carcinoma, hereditary disease, neurodegenerative disease, keratitis, colorectal adenocarcinoma, hepatocellular carcinoma, gastrointestinal stromal tumor.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 4 domains; 2 binding sites; 18 post-translational modification sites.
- Structural context: 1,983 variants have structural context.
- PTM context: 73 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable NTRK1 variants
Examples include M1?, M1I, M1K, M1L, L2L, L2M, L2Q, L2P. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- M1I (p.Met1Ile), rs2102878843, ClinGen CA342928810, ClinVar RCV001985821, MetaLR 0.49, MetaSVM 0.06, Likely pathogenic, Hereditary insensitivity to pain with anhidrosis
- M1K (p.Met1Lys), rs2102878838, ClinGen CA342928804, ClinVar RCV004515796, MetaLR 0.47, MetaSVM 0.05, Likely pathogenic, Hereditary insensitivity to pain with anhidrosis
- M1L (p.Met1Leu), rs1655612629, ClinGen CA342928796, ClinVar RCV001197778, MetaLR 0.44, MetaSVM -0.04, Uncertain significance, not provided
- L2L (p.Leu2Leu), gnomAD 1-156860938-C-T, CADD 12.80
- L2M (p.Leu2Met), gnomAD 1-156860938-C-A, REVEL 0.27, MetaLR 0.28
- L2Q (p.Leu2Gln), gnomAD 1-156860939-T-A, REVEL 0.14, MetaLR 0.15
- L2P (p.Leu2Pro), gnomAD 1-156860939-T-C, REVEL 0.39, MetaLR 0.28
- R3* (p.Arg3Ter), NCI-TCGA TCGA novel, CADD 37.00, Variant assessed as somatic; high impact.
- R3G (p.Arg3Gly), rs1655612729, ClinGen CA342928840, ClinVar RCV001279993, ClinVar RCV002542939, REVEL 0.29, MetaLR 0.19, Uncertain significance, Inborn genetic diseases
- R3P (p.Arg3Pro), TOPMed rs1655612857, REVEL 0.26, MetaLR 0.17, Uncertain significance, not provided
- R3R (p.Arg3Arg), rs755716153, gnomAD 1-156842153-C-A, REVEL 0.91, MetaLR 0.77
- R3W (p.Arg3Trp), rs755716153, gnomAD 1-156842153-C-T, REVEL 0.89, MetaLR 0.51
- R3Q (p.Arg3Gln), rs777419942, gnomAD 1-156842154-G-A, REVEL 0.92, MetaLR 0.39
- R3L (p.Arg3Leu), gnomAD 1-156860942-G-T, REVEL 0.24, MetaLR 0.17
- G4A (p.Gly4Ala), Ensembl rs1655613062
- G4S (p.Gly4Ser), rs556840308, ClinGen CA10606463, ClinVar RCV000346219, ClinVar RCV001085520, REVEL 0.14, MetaLR 0.16, Conflicting interpretations, Hereditary insensitivity to pain with anhidrosis; not provided; Inborn genetic d
- G4C (p.Gly4Cys), gnomAD 1-156860944-G-T, REVEL 0.31, MetaLR 0.39
- G4D (p.Gly4Asp), gnomAD 1-156860945-G-A, REVEL 0.22, MetaLR 0.25
- G4V (p.Gly4Val), gnomAD 1-156860945-G-T, REVEL 0.22, MetaLR 0.22
- G4G (p.Gly4Gly), rs757229319, gnomAD 1-156860946-C-T, CADD 10.50
- G5R (p.Gly5Arg), rs1382469625, ClinGen CA342928882, ClinVar RCV002389246, TOPMed rs1382469625, REVEL 0.10, MetaLR 0.08, Uncertain significance, Inborn genetic diseases
- G5* (p.Gly5Ter), gnomAD 1-156860947-G-T, CADD 34.00
- G5E (p.Gly5Glu), gnomAD 1-156860948-G-A, REVEL 0.13, MetaLR 0.09
- G5G (p.Gly5Gly), gnomAD 1-156860949-A-G, CADD 12.80
- R6P (p.Arg6Pro), Ensembl rs2102878903
- R6W (p.Arg6Trp), rs201472270, ClinGen CA1168813, cosmic curated COSV62328, ClinVar RCV000220958, REVEL 0.35, MetaLR 0.34, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- R6G (p.Arg6Gly), gnomAD 1-156860950-C-G, REVEL 0.28, MetaLR 0.20
- R6R (p.Arg6Arg), rs201472270, gnomAD 1-156860950-C-A, CADD 11.00
- R6L (p.Arg6Leu), gnomAD 1-156860951-G-T, REVEL 0.13, MetaLR 0.10
- R6Q (p.Arg6Gln), gnomAD 1-156860951-G-A, REVEL 0.09, MetaLR 0.08
- R7C (p.Arg7Cys), TOPMed rs1157244084, gnomAD rs1157244084, REVEL 0.17, MetaLR 0.14
- R7G (p.Arg7Gly), TOPMed rs1157244084, gnomAD rs1157244084
- R7H (p.Arg7His), gnomAD rs1286464365, REVEL 0.13, MetaLR 0.14, Uncertain significance, Inborn genetic diseases
- R7L (p.Arg7Leu), gnomAD rs1286464365, REVEL 0.10, MetaLR 0.11
- R7P (p.Arg7Pro), gnomAD rs1286464365, REVEL 0.23, MetaLR 0.14
- R7K (p.Arg7Lys), gnomAD 1-156842163-G-A, CADD 17.20, SIFT 0.02
- R7R (p.Arg7Arg), rs1032968973, gnomAD 1-156842164-A-G, CADD 10.60
- R7W (p.Arg7Trp), rs753223410, gnomAD 1-156842168-C-T, REVEL 0.91, MetaLR 0.73
- R7Q (p.Arg7Gln), rs756862919, gnomAD 1-156842169-G-A, CADD 40.00, SIFT 0.02
- R7S (p.Arg7Ser), gnomAD 1-156860953-C-A, REVEL 0.14, MetaLR 0.10
- G8E (p.Gly8Glu), rs1221586997, gnomAD rs1221586997, REVEL 0.15, MetaLR 0.13, Variant assessed as somatic; moderate impact.
- G8R (p.Gly8Arg), rs894958112, ClinGen CA342928936, ClinVar RCV001239738, TOPMed rs894958112, REVEL 0.10, MetaLR 0.13, Uncertain significance, Hereditary insensitivity to pain with anhidrosis
- G8W (p.Gly8Trp), TOPMed rs894958112, gnomAD rs894958112, REVEL 0.17, MetaLR 0.14, Uncertain significance
- G8V (p.Gly8Val), gnomAD 1-156860957-G-T, REVEL 0.15, MetaLR 0.15
- G8G (p.Gly8Gly), gnomAD 1-156860958-G-A, CADD 10.80
- Q9* (p.Gln9Ter), rs80356673, ClinGen CA342988, ClinVar RCV000030667, ClinVar RCV000031917, CADD 36.00, Pathogenic
- Q9K (p.Gln9Lys), TOPMed rs80356673, gnomAD rs80356673, REVEL 0.15, MetaLR 0.16, Pathogenic
- Q9P (p.Gln9Pro), rs1198447148, gnomAD 1-156842148-A-C, REVEL 0.94, MetaLR 0.59
- Q9R (p.Gln9Arg), gnomAD 1-156842148-A-G, REVEL 0.95, MetaLR 0.60
- Q9S (p.Gln9Ser), gnomAD 1-156860955-CG-C, CADD 22.30
- Q9H (p.Gln9His), gnomAD 1-156860961-G-T, REVEL 0.17, MetaLR 0.32
- Q9Q (p.Gln9Gln), gnomAD 1-156860961-G-A, CADD 8.04
- L10F (p.Leu10Phe), cosmic curated COSV62325, Ensembl rs1655615857, REVEL 0.09, MetaLR 0.15
- L10V (p.Leu10Val), Ensembl rs1655615857, REVEL 0.09, MetaLR 0.13
- L10L (p.Leu10Leu), rs771963500, gnomAD 1-156842182-G-A, CADD 7.00
- L10I (p.Leu10Ile), gnomAD 1-156860962-C-A, REVEL 0.09, MetaLR 0.09
- L10H (p.Leu10His), gnomAD 1-156860963-T-A, REVEL 0.42, MetaLR 0.18
- L10P (p.Leu10Pro), gnomAD 1-156860963-T-C, REVEL 0.33, MetaLR 0.13
- G11A (p.Gly11Ala), rs994643260, ClinGen CA31100980, ClinVar RCV001209950, TOPMed rs994643260, REVEL 0.15, MetaLR 0.08, Uncertain significance, Hereditary insensitivity to pain with anhidrosis
- G11V (p.Gly11Val), TOPMed rs994643260, gnomAD rs994643260, REVEL 0.21, MetaLR 0.28, Uncertain significance
- G11C (p.Gly11Cys), gnomAD 1-156860965-G-T, REVEL 0.25, MetaLR 0.28
- G11S (p.Gly11Ser), gnomAD 1-156860965-G-A, REVEL 0.05, MetaLR 0.07
- G11D (p.Gly11Asp), gnomAD 1-156860966-G-A, REVEL 0.18, MetaLR 0.22
- G11G (p.Gly11Gly), rs2102878965, gnomAD 1-156860967-C-T, CADD 12.50
- W12* (p.Trp12Ter), gnomAD rs1210177714, CADD 36.00
- W12C (p.Trp12Cys), gnomAD rs1210177714, REVEL 0.20, MetaLR 0.21
- W12R (p.Trp12Arg), ExAC rs750297580, gnomAD rs750297580, REVEL 0.15, MetaLR 0.07
- W12L (p.Trp12Leu), gnomAD 1-156860969-G-T, REVEL 0.20, MetaLR 0.15
- H13N (p.His13Asn), gnomAD rs1261080511, REVEL 0.14, MetaLR 0.15
- H13P (p.His13Pro), Ensembl rs2102878994
- p.His13 Trp15del, gnomAD 1-156860965-GGCTG, CADD 17.80
- H13Y (p.His13Tyr), gnomAD 1-156860971-C-T, REVEL 0.16, MetaLR 0.14
- H13L (p.His13Leu), gnomAD 1-156860972-A-T, REVEL 0.10, MetaLR 0.11
- H13R (p.His13Arg), gnomAD 1-156860972-A-G, REVEL 0.04, MetaLR 0.10
- H13Q (p.His13Gln), gnomAD 1-156860973-C-A, REVEL 0.12, MetaLR 0.09
- S14N (p.Ser14Asn), Ensembl rs2102879012, REVEL 0.13, MetaLR 0.16
- S14R (p.Ser14Arg), gnomAD rs1441623333, REVEL 0.16, MetaLR 0.12
- S14P (p.Ser14Pro), rs1654819440, gnomAD 1-156842165-T-C, REVEL 0.99, MetaLR 0.71
- S14T (p.Ser14Thr), gnomAD 1-156842165-T-A, REVEL 0.98, MetaLR 0.66
- S14Y (p.Ser14Tyr), rs1403617672, gnomAD 1-156842166-C-A, REVEL 0.98, MetaLR 0.77
- S14I (p.Ser14Ile), rs1654820812, gnomAD 1-156842193-G-T, REVEL 0.76, MetaLR 0.14
- S14G (p.Ser14Gly), gnomAD 1-156860974-A-G, REVEL 0.10, MetaLR 0.04
- S14S (p.Ser14Ser), rs1441623333, gnomAD 1-156860976-C-T, CADD 12.10
- W15G (p.Trp15Gly), gnomAD rs1210816787
- W15R (p.Trp15Arg), gnomAD rs1210816787, REVEL 0.08, MetaLR 0.05
- W15L (p.Trp15Leu), gnomAD 1-156860978-G-T, REVEL 0.17, MetaLR 0.10
- W15* (p.Trp15Ter), gnomAD 1-156860978-G-A, CADD 35.00
- W15C (p.Trp15Cys), gnomAD 1-156860979-G-T, REVEL 0.19, MetaLR 0.14
- A16S (p.Ala16Ser), TOPMed rs1239139469, gnomAD rs1239139469, REVEL 0.14, MetaLR 0.31
- A16L (p.Ala16Leu), gnomAD 1-156842153-CG-C, CADD 33.00
- A16D (p.Ala16Asp), rs2102853641, gnomAD 1-156842157-C-A, REVEL 0.77, MetaLR 0.76
- A16A (p.Ala16Ala), rs1654818830, gnomAD 1-156842158-T-C, CADD 5.25
- A16T (p.Ala16Thr), rs1307887055, gnomAD 1-156842159-G-A, REVEL 0.91, MetaLR 0.90
- A16P (p.Ala16Pro), rs1307887055, gnomAD 1-156842159-G-C, REVEL 0.88, MetaLR 0.69
- A16G (p.Ala16Gly), rs779943666, gnomAD 1-156842190-C-G, REVEL 0.62, MetaLR 0.65
- A16E (p.Ala16Glu), rs779943666, gnomAD 1-156842190-C-A, REVEL 0.39, MetaLR 0.29
- A16V (p.Ala16Val), gnomAD 1-156860981-C-T, REVEL 0.07, MetaLR 0.19
- A17V (p.Ala17Val), Ensembl rs2102879031, REVEL 0.12, MetaLR 0.12
- A17S (p.Ala17Ser), gnomAD 1-156860983-G-T, REVEL 0.14, MetaLR 0.08
- A17T (p.Ala17Thr), gnomAD 1-156860983-G-A, REVEL 0.15, MetaLR 0.09
- A17E (p.Ala17Glu), gnomAD 1-156860984-C-A, REVEL 0.21, MetaLR 0.07
- A17G (p.Ala17Gly), gnomAD 1-156860984-C-G, REVEL 0.14, MetaLR 0.12
- A17A (p.Ala17Ala), rs988922767, gnomAD 1-156860985-G-A, CADD 10.30
- G18E (p.Gly18Glu), rs1007211, ClinGen CA200337, cosmic curated COSV62325, ClinVar RCV000173175, REVEL 0.13, MetaLR 0.25, Benign/Likely benign, not provided; not specified; Hereditary insensitivity to pain with anhidrosis
- G18R (p.Gly18Arg), gnomAD 1-156860986-G-A, REVEL 0.17, MetaLR 0.28
- G18W (p.Gly18Trp), gnomAD 1-156860986-G-T, REVEL 0.30, MetaLR 0.40
- G18A (p.Gly18Ala), gnomAD 1-156860987-G-C, REVEL 0.07, MetaLR 0.06
- G18V (p.Gly18Val), gnomAD 1-156860987-G-T, REVEL 0.04, MetaLR 0.10
- G18G (p.Gly18Gly), rs1412756262, gnomAD 1-156860988-G-C, CADD 11.20
- P19Q (p.Pro19Gln), NCI-TCGA TCGA novel, REVEL 0.11, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- P19S (p.Pro19Ser), Ensembl rs2102879055, REVEL 0.11, MetaLR 0.12
- P19R (p.Pro19Arg), gnomAD 1-156860984-CG-C, CADD 22.10
- P19T (p.Pro19Thr), gnomAD 1-156860989-C-A, REVEL 0.11, MetaLR 0.14
- P19L (p.Pro19Leu), gnomAD 1-156860990-C-T, REVEL 0.12, MetaLR 0.05
- P19P (p.Pro19Pro), rs944894163, gnomAD 1-156860991-G-T, CADD 10.70
- G20D (p.Gly20Asp), rs781613716, ClinGen CA1168815, ClinVar RCV004496038, ExAC rs781613716, REVEL 0.37, MetaLR 0.29, Uncertain significance, Inborn genetic diseases
- G20S (p.Gly20Ser), rs1209117147, ClinGen CA342929155, ClinVar RCV002355696, ClinVar RCV005424873, REVEL 0.27, MetaLR 0.14, Uncertain significance, Inborn genetic diseases; not provided
- G20R (p.Gly20Arg), gnomAD 1-156860992-G-C, REVEL 0.39, MetaLR 0.14
- G20C (p.Gly20Cys), gnomAD 1-156860992-G-T, REVEL 0.42, MetaLR 0.36
- G20V (p.Gly20Val), gnomAD 1-156860993-G-T, REVEL 0.30, MetaLR 0.32
- G20G (p.Gly20Gly), rs2102879072, gnomAD 1-156860994-C-T, CADD 11.70
- S21C (p.Ser21Cys), gnomAD rs1402027172, REVEL 0.07, MetaLR 0.17, Uncertain significance
- S21G (p.Ser21Gly), rs1402027172, ClinGen CA342929163, ClinVar RCV001973449, gnomAD rs1402027172, REVEL 0.06, MetaLR 0.07, Uncertain significance, Hereditary insensitivity to pain with anhidrosis
- S21R (p.Ser21Arg), rs1269566553, ClinGen CA342929184, ClinVar RCV001908358, TOPMed rs1269566553, REVEL 0.08, MetaLR 0.09, Uncertain significance, Hereditary insensitivity to pain with anhidrosis
- S21T (p.Ser21Thr), gnomAD rs1415403729, REVEL 0.07, MetaLR 0.07
- S21N (p.Ser21Asn), gnomAD 1-156860996-G-A, REVEL 0.09, MetaLR 0.09
- S21I (p.Ser21Ile), gnomAD 1-156860996-G-T, REVEL 0.06, MetaLR 0.09
- S21S (p.Ser21Ser), gnomAD 1-156860997-C-T, CADD 13.90
- L22Q (p.Leu22Gln), rs748402400, ClinGen CA1168816, ClinVar RCV000525243, ExAC rs748402400, REVEL 0.35, MetaLR 0.37, Likely benign, Hereditary insensitivity to pain with anhidrosis
- L22L (p.Leu22Leu), gnomAD 1-156860998-C-T, CADD 12.80
- L22P (p.Leu22Pro), gnomAD 1-156860999-T-C, REVEL 0.45, MetaLR 0.40
- L23V (p.Leu23Val), gnomAD 1-156861001-C-G, REVEL 0.09, MetaLR 0.09
- L23L (p.Leu23Leu), gnomAD 1-156861001-C-T, CADD 13.30
- L23M (p.Leu23Met), gnomAD 1-156861001-C-A, REVEL 0.10, MetaLR 0.13
- L23P (p.Leu23Pro), gnomAD 1-156861002-T-C, REVEL 0.49, MetaLR 0.32
- A24S (p.Ala24Ser), rs886337406, ClinGen CA31101047, ClinVar RCV001929486, TOPMed rs886337406, REVEL 0.05, MetaLR 0.10, Uncertain significance, Hereditary insensitivity to pain with anhidrosis
- A24T (p.Ala24Thr), TOPMed rs886337406, gnomAD rs886337406, REVEL 0.07, MetaLR 0.09, Uncertain significance
- A24V (p.Ala24Val), Ensembl rs2102879104
- A24D (p.Ala24Asp), gnomAD 1-156861005-C-A, REVEL 0.32, MetaLR 0.15
- A24A (p.Ala24Ala), gnomAD 1-156861006-T-C, CADD 13.30
- W25* (p.Trp25Ter), Ensembl rs2102879109, CADD 38.00
- W25L (p.Trp25Leu), gnomAD 1-156861008-G-T, REVEL 0.20, MetaLR 0.06
- W25C (p.Trp25Cys), gnomAD 1-156861009-G-T, REVEL 0.38, MetaLR 0.18
- L26P (p.Leu26Pro), NCI-TCGA TCGA novel, REVEL 0.73, MetaLR 0.61, Variant assessed as somatic; moderate impact.
- L26L (p.Leu26Leu), gnomAD 1-156861010-C-T, CADD 13.40
- L26M (p.Leu26Met), gnomAD 1-156861010-C-A, REVEL 0.48, MetaLR 0.53
- L26Q (p.Leu26Gln), gnomAD 1-156861011-T-A, REVEL 0.64, MetaLR 0.61
- L28R (p.Leu28Arg), rs2525558110, ClinGen CA342929353, ClinVar RCV002445831, Uncertain significance, Inborn genetic diseases
- L28M (p.Leu28Met), gnomAD 1-156861016-C-A, REVEL 0.33, MetaLR 0.48
- L28L (p.Leu28Leu), rs1306918256, gnomAD 1-156861016-C-T, CADD 10.80
- L28P (p.Leu28Pro), gnomAD 1-156861017-T-C, REVEL 0.54, MetaLR 0.54
- L28Q (p.Leu28Gln), gnomAD 1-156861017-T-A, REVEL 0.48, MetaLR 0.54
- A29T (p.Ala29Thr), gnomAD 1-156861019-G-A, REVEL 0.10, MetaLR 0.12
- A29E (p.Ala29Glu), gnomAD 1-156861020-C-A, REVEL 0.07, MetaLR 0.13
- A29V (p.Ala29Val), gnomAD 1-156861020-C-T, REVEL 0.04, MetaLR 0.06
- S30C (p.Ser30Cys), Ensembl rs2102879132, Uncertain significance
- S30F (p.Ser30Phe), Ensembl rs2102879132, REVEL 0.11, MetaLR 0.12, Uncertain significance
- S30P (p.Ser30Pro), rs1350547406, ClinGen CA342929378, ClinVar RCV000822952, ClinVar RCV003279115, REVEL 0.08, MetaLR 0.10, Uncertain significance, Hereditary insensitivity to pain with anhidrosis; Inborn genetic diseases
- S30Y (p.Ser30Tyr), rs2102879132, ClinGen CA342929402, ClinVar RCV002376320, Ensembl rs2102879132, REVEL 0.25, MetaLR 0.10, Uncertain significance, Inborn genetic diseases
- S30S (p.Ser30Ser), gnomAD 1-156861024-T-C, CADD 8.46
- A31E (p.Ala31Glu), ExAC rs756222046, gnomAD rs756222046, REVEL 0.07, MetaLR 0.10, Uncertain significance
- A31V (p.Ala31Val), rs756222046, ClinGen CA342929440, ClinVar RCV001769318, ExAC rs756222046, REVEL 0.06, MetaLR 0.10, Uncertain significance, not provided
- A31T (p.Ala31Thr), gnomAD 1-156861025-G-A, REVEL 0.04, MetaLR 0.11
- A31S (p.Ala31Ser), gnomAD 1-156861025-G-T, REVEL 0.06, MetaLR 0.07
- A31G (p.Ala31Gly), gnomAD 1-156861026-C-G, REVEL 0.06, MetaLR 0.07
- A31A (p.Ala31Ala), gnomAD 1-156861027-G-T, CADD 9.35
- G32D (p.Gly32Asp), gnomAD rs1343765351, REVEL 0.25, MetaLR 0.21, Uncertain significance
- G32R (p.Gly32Arg), Ensembl rs2102879149
- G32V (p.Gly32Val), rs1343765351, ClinGen CA342929448, ClinVar RCV002011070, gnomAD rs1343765351, REVEL 0.28, MetaLR 0.25, Uncertain significance, Hereditary insensitivity to pain with anhidrosis
- G32A (p.Gly32Ala), gnomAD 1-156861026-CG-C, CADD 20.80
- G32S (p.Gly32Ser), gnomAD 1-156861028-G-A, REVEL 0.07, MetaLR 0.08
- G32G (p.Gly32Gly), gnomAD 1-156861030-C-G, CADD 11.90
- A33P (p.Ala33Pro), 1000Genomes rs777913530, ExAC rs777913530, TOPMed rs777913530, gnomAD rs777913530, REVEL 0.26, MetaLR 0.30, Uncertain significance
- A33S (p.Ala33Ser), rs777913530, ClinGen CA1168818, ClinVar RCV001941402, ClinVar RCV002386781, REVEL 0.14, MetaLR 0.16, Uncertain significance, Inborn genetic diseases; not provided; Hereditary insensitivity to pain with anh
- A33T (p.Ala33Thr), NCI-TCGA TCGA novel, 1000Genomes rs777913530, ExAC rs777913530, TOPMed rs777913530, REVEL 0.13, MetaLR 0.14, Uncertain significance, Hereditary insensitivity to pain with anhidrosis
- A33V (p.Ala33Val), gnomAD 1-156861032-C-T, REVEL 0.12, MetaLR 0.08
- A33A (p.Ala33Ala), gnomAD 1-156861033-C-G, CADD 7.47
- A34S (p.Ala34Ser), gnomAD rs1436042701, REVEL 0.07, MetaLR 0.10
- A34T (p.Ala34Thr), NCI-TCGA TCGA novel, gnomAD rs1436042701, REVEL 0.05, MetaLR 0.10, Variant assessed as somatic; moderate impact.
Public NTRK1 analysis runs
- NTRK1 analysis run — NTRK1 (3,221 variants) — completed 2026-08-10